Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-04-29
2010-02-16
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S071000
Reexamination Certificate
active
07662850
ABSTRACT:
Disclosed herein is a compound having a formulatherapeutic methods, compositions, and medicaments related thereto are also disclosed.
REFERENCES:
patent: 7091231 (2006-08-01), Donde
patent: 7429669 (2008-09-01), Old et al.
Patani, George A., Bioisosterism: A rational approach in drug design, Chem. Rev. 96 (1996) 3147-3176.
U.S. Appl. No. 10/599,046, filed Dec. 13, 2007, David W. Old.
U.S. Appl. No. 11/553,143, filed Jun. 7, 2007, Yariv Donde.
U.S. Appl. No. 11/774,411, filed May 22, 2008, David W. Old.
U.S. Appl. No. 11/775,283, filed Jan. 17, 2008, David W. Old.
Silverman: “Prodrugs and Drug Delivery Systems,” Organic Chem. of Drug Design and Drug Action, 2d ed., 2004, pp. 496-557.
Ngo Vinh X.
Old David W.
Allergan Inc.
Allergan, Inc.
Forrestal Kevin J.
Saeed Kamal A
Shterengarts Samantha L
LandOfFree
Therapeutic substituted chlorocyclopentanols does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic substituted chlorocyclopentanols, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic substituted chlorocyclopentanols will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4183068